Neil Josephson

Neil Josephson is a declared insider at 3 companies (senior executive); the most frequent names are Zymeworks Inc., Zymeworks BC Inc. and Iambic Therapeutics, Inc. Over a trading history stretching from 6 July 2021 to 14 October 2026, the count stands at 14 filings.

Both buying and selling appear: 2 purchases worth €63k, against 3 sales worth €60k. The net balance comes to €3,166 on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 4 share grants and 5 option exercises.

The newest entry dates from 16 October 2026: a share grant, in Iambic Therapeutics, Inc. The latest purchase dates back some time: it was published 1,746 days ago, on 11 January 2022. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.